Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.
Terrain Bio has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Terrain Bio's investors include Bruker, Olive Capital, Brainstorm Ventures, Uncommon Denominator, Hawktail Management.
Terrain Bio is headquartered in Cambridge, United States.
Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.
Terrain Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Terrain Bio — Funding & Investors." VCBacked, February 12, 2025, https://www.vcbacked.co/company/terrain-bio. Accessed September 30, 2026.
VCBacked. (2025). Terrain Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/terrain-bio
{{cite web |title=Terrain Bio — Funding & Investors |url=https://www.vcbacked.co/company/terrain-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated